Intrinsic Value of S&P & Nasdaq Contact Us

Health In Tech, Inc. HIT NASDAQ

NASDAQ Capital Marke • Technology • Software - Application • US • USD

SharesGrow Score
72/100
4/6 Pass
SharesGrow Intrinsic Value
$17.55
+1144.7%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Health In Tech, Inc. (HIT) trades at a trailing P/E of 59.9, forward P/E of 141.0. Trailing earnings yield is 1.67%, forward earnings yield 0.71%. PEG 0.90 (Peter Lynch undervalued ≤1.0). Graham Number is $0.40.

Criteria proven by this page:

  • VALUE (69/100, Pass) — PEG ≤ 1.0 — Peter Lynch undervalued (0.90).
  • PEG Ratio 0.90 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
  • Trailing Earnings Yield 1.67% — below bond yields — investors are paying a premium for expected growth rather than current earnings.

Overall SharesGrow Score: 70/100 with 4/7 criteria passed.

SharesGrow 7-Criteria Score
72/100
SG Score
View full scorecard →
VALUE
69/100
Price-to-Earnings & upside
Proven by this page
FUTURE
N/A
No coverage
PAST
100/100
→ Income
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
MOAT
35/100
→ Income
GROWTH
100/100
→ Income
INCOME
30/100
→ Income

Valuation Snapshot — HIT

Valuation Multiples
P/E (TTM)59.9
Forward P/E141.0
PEG Ratio0.90
Forward PEG0.08
P/B Ratio4.48
P/S Ratio2.22
EV/EBITDA25.8
Per Share Data
EPS (TTM)$0.02
Forward EPS (Est.)$0.01
Book Value / Share$0.31
Revenue / Share$0.60
FCF / Share$-93,449.50
Yields & Fair Value
Earnings Yield1.67%
Forward Earnings Yield0.71%
Dividend Yield0.00%
Graham Number$0.40
SharesGrow IV$17.55 (+1144.7%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2022 3,458.1 0.00 262.49 47.79 -
2023 111.3 0.04 45.26 14.40 -
2024 536.0 -6.86 27.29 18.44 -
2025 69.4 0.69 5.19 2.66 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2022 $0.00 $5.77M $79.74K 1.4%
2023 $0.05 $19.15M $2.48M 12.9%
2024 $0.01 $19.49M $670.48K 3.4%
2025 $0.02 $33.33M $1.28M 3.8%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $0.01 $0.01 – $0.01 $43.82M $43.59M – $44.05M 2
2027 $0.20 $0.20 – $0.20 $80.1M $79.67M – $80.53M 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message